5 minutes | Friday, 2 November 2018
It’s been a contentiously fought battle for a long time but on 1 November the UK allowed for medical practitioners to legally prescribe CBD products - otherwise known as medicinal cannabis.
For many dealing with issues such as epilepsy or chronic pain, this may mean a much higher quality of life, but as the industry grows, many companies are looking to mass produce CBD extracts whilst compromising on quality and consumer health.
Here to tell us more is biotechnician from Endoca, Henry Vincenty.